Understanding these mechanisms highlights the complex interplay between immune regulation and metabolic disorders and suggests that targeting PD-L1 pathways could be a potential strategy for managing obesity-related inflammation and its associated health complications [22,25]. This evidence concerns the gene CD274 and Obesity.